Anastrozole Tablets, USP, 1 mg, a) 30-count (NDC 68001-155-04) and 1000-count (NDC 68001-155-08) bottles, Rx Only, Manufactured by: Cadila Healthcare Ltd., Ahmedabad, India For BluePoint Laboratories

Recall Number: D-1467-2019

Firm: American Health Packaging

Classification: Class II

Status: Terminated

Report Date: 20190717

Initiation Date: 20190509

Termination Date: 20200909

Reason for Recall

GMP Deviations: Potential cross contamination due to cleaning procedure failure.

Product Description

Anastrozole Tablets, USP, 1 mg, a) 30-count (NDC 68001-155-04) and 1000-count (NDC 68001-155-08) bottles, Rx Only, Manufactured by: Cadila Healthcare Ltd., Ahmedabad, India For BluePoint Laboratories